About 22CEMIT

22CEMIT is a non-profit, general incorporated association aimed at delivering the best treatment to cancer patients by conducting a business to exchange and share the knowledge of all healthcare professionals involved in cancer treatment.

What’s New

Apr. 4, 2022
NEW! Takayuki Yoshino, chairman of 22CEMIT, has been appointed as deputy director (Research) of the National Cancer Center Hospital East.
March 30, 2022
Takayuki Yoshino spoke at the LDP's special committee!

Event

The 8th Opinion Exchange Meeting on the Forefront of Industry-Government-Academia Cancer Genome Medicine
Saturday, May 7, 2022 09:00-13:00
Read more.

Corporate members of 22CEMIT

(Syllable order)
6th_sankan_lilly
6th_sankan_chugai
ep-crsu

Websites provided by 22CEMIT

A site where you can learn about the latest cancer genome medicine

Related medical institutes and academic societies